Cindy Tahl - Oct 1, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
General Counsel and Secretary
Signature
/s/ Cindy Tahl
Stock symbol
FATE
Transactions as of
Oct 1, 2021
Transactions value $
-$2,613,962
Form type
4
Date filed
10/4/2021, 04:12 PM
Previous filing
Jan 27, 2022
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $328K +50K +46.28% $6.55 158K Oct 1, 2021 Direct F1
transaction FATE Common Stock Sale -$947K -16.3K -10.32% $58.03* 142K Oct 1, 2021 Direct F1, F2
transaction FATE Common Stock Sale -$1.29M -21.8K -15.41% $58.96* 120K Oct 1, 2021 Direct F1, F3
transaction FATE Common Stock Sale -$707K -11.8K -9.88% $59.68* 108K Oct 1, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -50K -30% $0.00 117K Oct 1, 2021 Common Stock 50K $6.55 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
F2 Represents the weighted average sale price of the shares sold ranging from $57.41 to $58.36 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 4.
F3 Represents the weighted average sale price of the shares sold ranging from $58.45 to $59.44 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $59.45 to $60.07 per share.
F5 This option is fully vested.